Trinucleotide repeat dynamic mutation identifying susceptibility in familial and sporadic chronic lymphocytic leukaemia

British Journal of Haematology

Volumn 136, Issue 1, 2007, Pages 73-79

  Auer, Rebecca L ^a   Dighiero, Guillaume ^b   Goldin, Lynn R ^c   Syndercombe Court, Denise ^a   Jones, Christopher ^a   McElwaine, Suzanne ^a   Newland, Adrian C ^a   Fegan, Christopher D ^d   Caporaso, Neil ^c   Cotter, Finbarr E ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b INSTITUT PASTEUR   (France)

^c NATIONAL CANCER INSTITUTE   (United States)

^d Cardiff and Vales NHS Trust   (United Kingdom)

Author keywords

Anticipation; Chronic lymphocytic leukaemia; Familial chronic lymphocytic leukaemia; Trinucleotide repeats

Indexed keywords

ADULT; AGED; ARTICLE; CHROMOSOME ANALYSIS; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; DISEASE COURSE; GENE AMPLIFICATION; GENE LOCUS; GENE SEQUENCE; GENETIC IDENTIFICATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; TRINUCLEOTIDE REPEAT;

AGE OF ONSET; ANALYSIS OF VARIANCE; ANTICIPATION, GENETIC; CASE-CONTROL STUDIES; DNA MUTATIONAL ANALYSIS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HOMOZYGOTE; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC; MUTATION; POLYMERASE CHAIN REACTION; STATISTICS, NONPARAMETRIC; TRINUCLEOTIDE REPEATS;

EID: 33845505494     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2006.06388.x     Document Type: Article

References (43)

1. Auer, R.L., Jones, C., Mullenbach, R.A., Syndercombe-Court, D., Milligan, D.W., Fegan, C.D. & Cotter, F.E. (2001) Role for CCG-trinucleotide repeats in the pathogenesis of chronic lymphocytic leukemia. Blood, 97, 509-515.
2. Benzow, K.A., Koob, M.D., Condie, A., Catovsky, D., Matutes, E., Yuille, M.R. & Houlston, R.S. (2002) Instability of CAG-trinucleotide repeats in chronic lymphocytic leukemia. Leukemia & Lymphoma, 43, 1987-1990.
3. Brais, B., Bouchard, J.P., Xie, Y.G., Rochefort, D.L., Chretien, N., Tome, F.M., Lafreniere, R.G., Rommens, J.M., Uyama, E., Nohira, O., Blumen, S., Korczyn, A.D., Heutink, P., Mathieu, J., Duranceau, A., Codere, F., Fardeau, M. & Rouleau, G.A. (1998) Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy. Nature Genetics, 18, 164-167.
4. Brook, J.D., McCurrach, M.E., Harley, H.G., Buckler, A.J., Church, D., Aburatani, H., Hunter, K., Stanton, V.P., Thirion, J.P., Hudson, T., Sohn, R., Zemelman, B., Snell, R.G., Rundle, S.A., Crow, S., Davies, J., Shelbourne, P., Buxton, J., Jones, C., Juvonen, V., Johnson, K., Harper, P.S., Shaw, D.J. & Housman, D.E. (1992) Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell, 68, 799-808.
5. Capalbo, S., Trerotoli, P., Ciancio, A., Battista, C., Serio, G. & Liso, V. (2000) Increased risk of lymphoproliferative disorders in relatives of patients with B-cell chronic lymphocytic leukemia: relevance of the degree of familial linkage. European Journal of Haematology, 65, 114-117.
6. Catovsky, D. (1997) The search for genetic clues in chronic lymphocytic leukemia. Hematology Cell Therapy, 39 (Suppl. 1), S5-S11.
7. Chang, B.L., Zheng, S.L., Hawkins, G.A., Isaacs, S.D., Wiley, K.E., Turner, A., Carpten, J.D., Bleecker, E.R., Walsh, P.C., Trent, J.M., Meyers, D.A., Isaacs, W.B. & Xu, J. (2002) Polymorphic GGC repeats in the androgen receptor gene are associated with hereditary and sporadic prostate cancer risk. Human Genetics, 110, 122-129.
8. Daugherty, S.E., Pfeiffer, R.M., Mellemkjaer, L., Hemminki, K. & Goldin, L.R. (2005) No evidence for anticipation in lymphoproliferative tumors in population-based samples. Cancer Epidemiology Biomarkers & Prevention, 14, 1245-1250.
9. De Lord, C., Powles, R., Mehta, J., Wilson, K., Treleaven, J., Meller, S. & Catovsky, D. (1998) Familial acute myeloid leukaemia: four male members of a single family over three consecutive generations exhibiting anticipation. British Journal of Haematology, 100, 557-560.
10. Edwards, S.M., Badzioch, M.D., Minter, R., Hamoudi, R., Collins, N., Ardern-Jones, A., Dowe, A., Osborne, S., Kelly, J., Shearer, R., Easton, D.F., Saunders, G.F., Dearnaley, D.P. & Eeles, R.A. (1999) Androgen receptor polymorphisms: association with prostate cancer risk, relapse and overall survival. International Journal of Cancer, 84, 458-465.
11. Ferro, P., dell'Eva, R. & Pfeffer, U. (2001) Are there CAG repeat expansion-related disorders outside the central nervous system? Brain Research Bulletin, 56, 259-264.
12. Fraser, F.C. (1997) Trinucleotide repeats not the only cause of anticipation. Lancet, 350, 459-460.
13. Ginsberg, D., Vairo, G., Chittenden, T., Xiao, Z.X., Xu, G., Wydner, K.L., DeCaprio, J.A., Lawrence, J.B. & Livingston, D.M. (1994) E2F-4, a new member of the E2F transcription factor family, interacts with p107. Genes & Development, 8, 2665-2679.
14. Giovannucci, E., Stampfer, M.J., Krithivas, K., Brown, M., Dahl, D., Brufsky, A., Talcott, J., Hennekens, C.H. & Kantoff, P.W. (1997) The CAG repeat within the androgen receptor gene and its relationship to prostate cancer. Proceedings of the National Academy of Sciences of the United States of America, 94, 3320-3323.
15. Goldin, L.R., Sgambati, M., Marti, G.E., Fontaine, L., Ishibe, N. & Caporaso, N. (1999) Anticipation in familial chronic lymphocytic leukemia. American Journal of Human Genetics, 65, 265-269.
16. Horwitz, M. (1997) The genetics of familial leukemia. Leukemia, 11, 1347-1359.
17. Horwitz, M., Goode, E.L. & Jarvik, G.P. (1996) Anticipation in familial leukemia. American Journal of Human Genetics, 59, 990-998.
18. Horwitz, M., Benson, K.F., Li, F.Q., Wolff, J., Leppert, M.F., Hobson, L., Mangelsdorf, M., Yu, S., Hewett, D., Richards, R.I. & Raskind, W.H. (1997) Genetic heterogeneity in familial acute myelogenous leukemia: evidence for a second locus at chromosome 16q21-23.2. American Journal of Human Genetics, 61, 873-881.
19. Jones, C., Penny, L., Mattina, T., Yu, S., Baker, E., Voullaire, L., Langdon, W.Y., Sutherland, G.R., Richards, R.I. & Tunnacliffe, A. (1995) Association of a chromosome deletion syndrome with a fragile site within the proto-oncogene CBL2. Nature, 376, 145-149.
20. Kawaguchi, Y., Okamoto, T., Taniwaki, M., Aizawa, M., Inoue, M., Katayama, S., Kawakami, H., Nakamura, S., Nishimura, M., Akiguchi, I., Kimura, J., Narumiya, S. & Kakizuka, A. (1994) CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Nature Genetics, 8, 221-228.
21. Kenneson, A., Zhang, F., Hagedorn, C.H. & Warren, S.T. (2001) Reduced FMRP and increased FMR1 transcription is proportionally associated with CGG repeat number in intermediate-length and premutation carriers. Human Molecular Genetics, 10, 1449-1454.
22. King, B.L., Peng, H.Q., Goss, P., Huan, S., Bronson, D., Kacinski, B.M. & Hogg, D. (1997) Repeat expansion detection analysis of (CAG)n tracts in tumor cell lines, testicular tumors, and testicular cancer families. Cancer Research, 57, 209-214.
23. Kremer, E.J., Pritchard, M., Lynch, M., Yu, S., Holman, K., Baker, E., Warren, S.T., Schlessinger, D., Sutherland, G.R. & Richards, R.I. (1991) Mapping of DNA instability at the fragile X to a trinucleotide repeat sequence p (CCG)n. Science, 252, 1711-1714.
24. La Spada, A.R., Wilson, E.M., Lubahn, D.B., Harding, A.E. & Fischbeck, K.H. (1991) Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature, 352, 77-79.
25. Nagafuchi, S., Yanagisawa, H., Sato, K., Shirayama, T., Ohsaki, E., Bundo, M., Takeda, T., Tadokoro, K., Kondo, I., Murayama, N., Tanaka, Y., Kikushima, H., Umino, K., Kurosawa, H., Furukawa, T., Nihei, K., Inoue, T., Sano, T., Komure, O., Takahashi, M., Yoshizawa, I., Kanazawa, I. & Yamada, M. (1994) Dentatorubral and pallidoluysian atrophy expansion of an unstable CAG trinucleotide on chromosome 12p. Nature Genetics, 6, 14-18.
26. Nancarrow, J.K., Kremer, E., Holman, K., Eyre, H., Doggett, N.A., Le Paslier, D., Callen, D.F., Sutherland, G.R. & Richards, R.I. (1994) Implications of FRA16A structure for the mechanism of chromosomal fragile site genesis. Science, 264, 1938-1941.
27. Nelson, K.A. & Witte, J.S. (2002) Androgen receptor CAG repeats and prostate cancer. American Journal of Epidemiology, 155, 883-890.
28. Orr, H.T., Chung, M.Y., Banfi, S., Kwiatkowski, Jr, T.J., Servadio, A., Beaudet, A.L., McCall, A.E., Duvick, L.A., Ranum, L.P. & Zoghbi, H.Y. (1993) Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1. Nature Genetics, 4, 221-226.
29. Parrish, J.E., Oostra, B.A., Verkerk, A.J., Richards, C.S., Reynolds, J., Spikes, A.S., Shaffer, L.G. & Nelson, D.L. (1994) Isolation of a GCC repeat showing expansion in FRAXF, a fragile site distal to FRAXA and FRAXE. Nature Genetics, 8, 229-235.
30. Pfeffer, U., Ferro, P., Pavia, V., Trombino, S., Dell'Eva, R., Merlo, G. & Levi, G. (2001) The coding region of the human DLX6 gene contains a polymorphic CAG/CCG repeat. International Journal of Oncology, 18, 1293-1297.
31. Rebbeck, T.R., Kantoff, P.W., Krithivas, K., Neuhausen, S., Blackwood, M.A., Godwin, A.K., Daly, M.B., Narod, S.A., Garber, J.E., Lynch, H.T., Weber, B.L. & Brown, M. (1999) Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat. American Journal of Human Genetics, 64, 1371-1377.
32. Richards, R.I., Crawford, J., Narahara, K., Mangelsdorf, M., Friend, K., Staples, A., Denton, M., Easteal, S., Hori, T.A., Kondo, I., Jenkins, T., Goldman, A., Panich, V., Ferakova, E. & Sutherland, G.R. (1996) Dynamic mutation loci: allele distributions in different populations. Annals of Human Genetics, 60, 391-400.
33. Richetta, A., Ottini, L., Falchetti, M., Innocenzi, D., Bottoni, U., Faiola, R., Mariani-Costantini, R. & Calvieri, S. (2001) Instability at sequence repeats in melanocytic tumours. Melanoma Research, 11, 283-289.
34. Sasaki, M., Dahiya, R., Fujimoto, S., Ishikawa, M. & Oshimura, M. (2000) The expansion of the CAG repeat in exon 1 of the human androgen receptor gene is associated with uterine endometrial carcinoma. Molecular Carcinogenesis, 27, 237-244.
35. Shah, N.P., Witte, O.N. & Denny, C.T. (1991) Characterization of the BCR promoter in Philadelphia chromosome-positive and -negative cell lines. Molecular and Cellular Biology, 11, 1854-1860.
36. Stanford, J.L., Just, J.J., Gibbs, M., Wicklund, K.G., Neal, C.L., Blumenstein, B.A. & Ostrander, E.A. (1997) Polymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk. Cancer Research, 57, 1194-1198.
37. Strissel, P.L., Strick, R., Tomek, R.J., Roe, B.A., Rowley, J.D. & Zeleznik-Le, N.J. (2000) DNA structural properties of AF9 are similar to MLL and could act as recombination hot spots resulting in MLL/AF9 translocations and leukemogenesis. Human Molecular Genetics, 9, 1671-1679.
38. Sutherland, G.R. & Richards, R.I. (1995) Simple tandem DNA repeats and human genetic disease. Proceedings of the National Academy of Sciences of the United States of America, 92, 3636-3641.
39. The Huntington's Disease Collaborative Research Group. (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell, 72, 971-983.
40. Walker, G.J., Walters, M.K., Palmer, J.M. & Hayward, N.K. (1994) The MLLT3 gene maps between D9S156 and D9S171 and contains an unstable polymorphic trinucleotide repeat. Genomics, 20, 490-491.
41. Wiernik, P.H., Ashwin, M., Hu, X.P., Paietta, E. & Brown, K. (2001) Anticipation in familial chronic lymphocytic leukaemia. British Journal of Haematology, 113, 407-414.
42. Yuille, M.R., Houlston, R.S. & Catovsky, D. (1998) Anticipation in familial chronic lymphocytic leukaemia. Leukemia, 12, 1696-1698.
43. Yuille, M.R., Matutes, E., Marossy, A., Hilditch, B., Catovsky, D. & Houlston, R.S. (2000) Familial chronic lymphocytic leukaemia: a survey and review of published studies. British Journal of Haematology, 109, 794-799.